Clinical Trial Update: Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of ZSP1273 in participants with severe kidney impairment has completed, aiming to understand how kidney disease affects drug expos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ZSP1273

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Kidney Impairment | Phase 1 | Status: COMPLETED